EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Insulin‐like growth factor binding Protein‐4: A novel indicator of pulmonary arterial hypertension severity and survival

Guillermo Torres iD, Jun Yang iD, Megan Griffiths, Stephanie Brandal, Rachel Damico, Dhananjay Vaidya, Catherine E Simpson iD, Michael W Pauciulo, William C Nichols, David D Ivy, Eric D Austin, Paul M Hassoun und 1 weitere

Pulmonary Circulation · 2023-04 · 13 (2)

DOI: 10.1002/pul2.12235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pulmonary Circulation, online erschienen am 03.05.2023. Verfasst von Guillermo Torres und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Cardiology, Department of Pediatrics Johns Hopkins University Baltimore Maryland USA. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteomic analysis of patients with pulmonary arterial hypertension (PAH) has demonstrated significant abnormalities in the insulin‐like growth factor axis (IGF). This study proposed to establish associations between a specific binding protein, insulin‐like growth factor binding protein 4 (IGFBP4), and PAH severity as well as survival across varying study cohorts. In all cohorts studied, serum IGFBP4 levels were significantly elevated in PAH compared to controls ( p < 0.0001). IGFBP4 concentration was also highest in the connective tissue‐associated PAH (CTD‐PAH) and idiopathic PAH subtypes (876 and 784 ng/mL, median, respectively). After adjustment for age and sex, IGFBP4 was significantly associated with worse PAH severity as defined by a decreased 6‐min walk distance (6MWD), New York heart association functional class (NYHA‐FC), REVEAL 2.0 score and higher right atrial pressures. In longitudinal analysis provided by one of the study cohorts, IGFBP4 was prospectively significantly associated with a shorter 6MWD, worse NYHA‐FC classification, and decreased survival. Cox multivariable analysis demonstrated higher serum IGFBP4 as an independent predictor of survival in the overall PAHB cohort. Therefore, this study established that higher circulating IGFBP4 levels were significantly associated with worse PAH severity, decreased survival and disease progression. Dysregulation of IGF metabolism/growth axis may play a significant role in PAH cardio‐pulmonary pathobiology.

Schlagwörter

Stichwörter der Autor:innen

biomarkeroutcomesprognosisproteomics

Autor:innen und Institutionen

  • Division of Pediatric Cardiology, Department of Pediatrics Johns Hopkins University Baltimore Maryland USA.
  • Division of Pediatric Cardiology, Department of Pediatrics University of Texas Southwestern Medical Center Dallas Texas USA.
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine Johns Hopkins University Baltimore Maryland USA.
  • Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA.
  • Division of General Internal Medicine Johns Hopkins School of Medicine Baltimore Maryland USA.
  • Division of Human Genetics, Department of Pediatrics Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine Cincinnati Ohio USA.

ORCID-Profile: Guillermo Torres, Jun Yang, Catherine E Simpson

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Torres, G., Yang, J., Griffiths, M., Brandal, S., Damico, R., Vaidya, D., Simpson, C. E., Pauciulo, M. W., Nichols, W. C., Ivy, D. D., Austin, E. D., Hassoun, P. M., & Everett, A. D. (2023). Insulin‐like growth factor binding Protein‐4: A novel indicator of pulmonary arterial hypertension severity and survival. Pulmonary Circulation, 13(2). https://doi.org/10.1002/pul2.12235

Vancouver

Torres G, Yang J, Griffiths M, Brandal S, Damico R, Vaidya D, et al. Insulin‐like growth factor binding Protein‐4: A novel indicator of pulmonary arterial hypertension severity and survival. Pulmonary Circulation. 2023;13(2). doi:10.1002/pul2.12235

BibTeX
@article{Torres2023,
  author = {Torres, Guillermo and Yang, Jun and Griffiths, Megan and Brandal, Stephanie and Damico, Rachel and Vaidya, Dhananjay and Simpson, Catherine E and Pauciulo, Michael W and Nichols, William C and Ivy, David D and Austin, Eric D and Hassoun, Paul M and Everett, Allen D},
  title = {Insulin‐like growth factor binding Protein‐4: A novel indicator of pulmonary arterial hypertension severity and survival},
  journal = {Pulmonary Circulation},
  year = {2023},
  volume = {13},
  number = {2},
  doi = {10.1002/pul2.12235}
}
Kostenlos starten →